ישראל - עברית - Ministry of Health

comex ltd - pregnant mare serum gonadotrophin - אבקה להכנת תמיסה לזריקה - pregnant mare serum gonadotrophin 6000 iu

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - טיפוח העור

ישראל - עברית - Ministry of Health

תעשיות חלאבין בעמ - לחות לעור

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - pregnant mare serum gonadotrophin - אבקה להכנת תמיסה לזריקה - pregnant mare serum gonadotrophin 600 iu/vial

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - pregnant mare serum gonadotrophin - אבקה להכנת תמיסה לזריקה - pregnant mare serum gonadotrophin 600 iu/vial

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - pregnant mare serum gonadotrophin - אבקה להכנת תמיסה לזריקה - pregnant mare serum gonadotrophin 6000 iu/vial

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - pregnant mare serum gonadotrophin - אבקה להכנת תמיסה לזריקה - pregnant mare serum gonadotrophin 6000 iu/vial

ישראל - עברית - Ministry of Health

בן שמעון פלוריש בעמ - משחה לתינוק להגנה, למניעה וטיפול בתפרחת חיתולים

ישראל - עברית - Ministry of Health

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat

ישראל - עברית - Ministry of Health

j-c health care ltd - recombinant human erythropoietin - תמיסה להזרקה - recombinant human erythropoietin 2000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of severe anemia associated with chronic renal failure, anemia in zidovudine treated hiv infected patients, anemia in cancer patients on chemotherapy.to increase the yield of autologous blood from patients in a predonation programme initiated to avoid the use of homologous blood. treatment is indicated in patients with moderate anemia (packed cell volume (pcv) approximately 33 to 39% , no iron deficiency) if blood conserving procedures are not available or insufficient either: a: when the scheduled major elective surgery requires a large volume of blood ( 4 or more units of blood for females or 5 or more units for males) or b: when the period necessary to obtain the required volume of autologous blood is too short. perisurgery: reduction of allogeneic blood transfusion in surgery patients : eprex is indicated for the treatment of anemic patients (hemoglobin 9-11 g/dl) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions. eprex is indicat